Alzheimer's and dementia currently have significant unmet medical needs, and there are a host of challenges with the appropriate design of clinical trials and endpoints.
Alzheimer's & Brain Awareness Month: A Conversation with Eisai.
As part of Alzheimer’s & Brain Awareness Month, I sat down with Shobha Dhadda, Ph.D., Chief Clinical Science and Operations Officer, Eisai. We discussed how Alzheimer's and dementia currently have significant unmet medical needs and how there are a host of challenges with the appropriate design of clinical trials and endpoints. We also talked about how Eisai is continuing to innovate on their treatment for Alzheimer’s, even after one of their medicines has received FDA approval. Learn about progress in this space in the video below.
